

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.40648322 |
| 2 | nuclear pore complex assembly (GO:0051292) | 4.30313915 |
| 3 | NADH metabolic process (GO:0006734) | 4.18237049 |
| 4 | mitotic chromosome condensation (GO:0007076) | 4.16620792 |
| 5 | * tricarboxylic acid cycle (GO:0006099) | 4.09790346 |
| 6 | formation of translation preinitiation complex (GO:0001731) | 4.03992148 |
| 7 | DNA unwinding involved in DNA replication (GO:0006268) | 3.94525260 |
| 8 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.94297475 |
| 9 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.90826044 |
| 10 | oxidative phosphorylation (GO:0006119) | 3.87051766 |
| 11 | regulation of translational fidelity (GO:0006450) | 3.85550466 |
| 12 | nuclear pore organization (GO:0006999) | 3.80151994 |
| 13 | DNA strand elongation (GO:0022616) | 3.78415850 |
| 14 | mitotic sister chromatid segregation (GO:0000070) | 3.64976605 |
| 15 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.56524488 |
| 16 | ribosomal large subunit biogenesis (GO:0042273) | 3.55220715 |
| 17 | establishment of integrated proviral latency (GO:0075713) | 3.54342022 |
| 18 | ATP synthesis coupled proton transport (GO:0015986) | 3.50709035 |
| 19 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.50709035 |
| 20 | oxaloacetate metabolic process (GO:0006107) | 3.49934226 |
| 21 | ribosomal small subunit biogenesis (GO:0042274) | 3.48657880 |
| 22 | L-serine metabolic process (GO:0006563) | 3.47934612 |
| 23 | sister chromatid segregation (GO:0000819) | 3.33613077 |
| 24 | ribosome assembly (GO:0042255) | 3.27311122 |
| 25 | DNA replication checkpoint (GO:0000076) | 3.24596796 |
| 26 | mitotic metaphase plate congression (GO:0007080) | 3.24319591 |
| 27 | pore complex assembly (GO:0046931) | 3.22213660 |
| 28 | regulation of mitochondrial translation (GO:0070129) | 3.20203966 |
| 29 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.18988400 |
| 30 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.16522240 |
| 31 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.13738512 |
| 32 | purine nucleobase biosynthetic process (GO:0009113) | 3.12782238 |
| 33 | COPI coating of Golgi vesicle (GO:0048205) | 3.12018757 |
| 34 | Golgi transport vesicle coating (GO:0048200) | 3.12018757 |
| 35 | protein localization to chromosome, centromeric region (GO:0071459) | 3.11886894 |
| 36 | IMP metabolic process (GO:0046040) | 3.09801956 |
| 37 | tRNA aminoacylation for protein translation (GO:0006418) | 3.09255022 |
| 38 | proteasome assembly (GO:0043248) | 3.08111739 |
| 39 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.07431768 |
| 40 | IMP biosynthetic process (GO:0006188) | 3.06193180 |
| 41 | maturation of SSU-rRNA (GO:0030490) | 3.04640265 |
| 42 | mitotic nuclear envelope disassembly (GO:0007077) | 3.04552771 |
| 43 | regulation of mitotic spindle organization (GO:0060236) | 3.01847211 |
| 44 | viral transcription (GO:0019083) | 3.01506372 |
| 45 | proline biosynthetic process (GO:0006561) | 3.00933828 |
| 46 | serine family amino acid biosynthetic process (GO:0009070) | 3.00870544 |
| 47 | tRNA aminoacylation (GO:0043039) | 3.00584799 |
| 48 | amino acid activation (GO:0043038) | 3.00584799 |
| 49 | protein localization to kinetochore (GO:0034501) | 3.00558135 |
| 50 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.99969936 |
| 51 | urea metabolic process (GO:0019627) | 2.99405305 |
| 52 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.99019238 |
| 53 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.98095822 |
| 54 | gluconeogenesis (GO:0006094) | 2.97660374 |
| 55 | respiratory electron transport chain (GO:0022904) | 2.96639805 |
| 56 | translational termination (GO:0006415) | 2.95867220 |
| 57 | folic acid metabolic process (GO:0046655) | 2.94612645 |
| 58 | urea cycle (GO:0000050) | 2.93546872 |
| 59 | ribosomal small subunit assembly (GO:0000028) | 2.92968298 |
| 60 | DNA replication initiation (GO:0006270) | 2.92891362 |
| 61 | negative regulation of ligase activity (GO:0051352) | 2.91225329 |
| 62 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.91225329 |
| 63 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.89568331 |
| 64 | telomere maintenance via recombination (GO:0000722) | 2.86410485 |
| 65 | cotranslational protein targeting to membrane (GO:0006613) | 2.84825482 |
| 66 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.84779318 |
| 67 | electron transport chain (GO:0022900) | 2.84131641 |
| 68 | nucleobase biosynthetic process (GO:0046112) | 2.83698728 |
| 69 | translational initiation (GO:0006413) | 2.83507805 |
| 70 | nuclear envelope disassembly (GO:0051081) | 2.81665307 |
| 71 | membrane disassembly (GO:0030397) | 2.81665307 |
| 72 | protein targeting to ER (GO:0045047) | 2.80724207 |
| 73 | metaphase plate congression (GO:0051310) | 2.80682551 |
| 74 | tetrahydrofolate metabolic process (GO:0046653) | 2.80270399 |
| 75 | mitotic recombination (GO:0006312) | 2.80009753 |
| 76 | hexose biosynthetic process (GO:0019319) | 2.77920542 |
| 77 | CENP-A containing nucleosome assembly (GO:0034080) | 2.76350765 |
| 78 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.76045253 |
| 79 | nitrogen cycle metabolic process (GO:0071941) | 2.74723773 |
| 80 | kinetochore organization (GO:0051383) | 2.72080529 |
| 81 | mitochondrial fusion (GO:0008053) | 2.72043141 |
| 82 | monosaccharide biosynthetic process (GO:0046364) | 2.71719664 |
| 83 | L-phenylalanine metabolic process (GO:0006558) | 2.71711724 |
| 84 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.71711724 |
| 85 | ventricular cardiac muscle cell development (GO:0055015) | 2.71022541 |
| 86 | aerobic respiration (GO:0009060) | 2.70635001 |
| 87 | regulation of spindle organization (GO:0090224) | 2.70622711 |
| 88 | glyoxylate metabolic process (GO:0046487) | 2.70302430 |
| 89 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.70012975 |
| 90 | protein localization to endoplasmic reticulum (GO:0070972) | 2.69455698 |
| 91 | establishment of viral latency (GO:0019043) | 2.69373997 |
| 92 | ribosome biogenesis (GO:0042254) | 2.68859413 |
| 93 | muscle filament sliding (GO:0030049) | 2.68507738 |
| 94 | actin-myosin filament sliding (GO:0033275) | 2.68507738 |
| 95 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.67965151 |
| 96 | translational elongation (GO:0006414) | 2.67948514 |
| 97 | protein maturation by protein folding (GO:0022417) | 2.66617731 |
| 98 | inner mitochondrial membrane organization (GO:0007007) | 2.65059420 |
| 99 | DNA topological change (GO:0006265) | 2.62743413 |
| 100 | midgut development (GO:0007494) | 2.62704398 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.37513800 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.33100574 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.01760132 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.69007574 |
| 5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.58757189 |
| 6 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.54844402 |
| 7 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.12411762 |
| 8 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.06174056 |
| 9 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.96025092 |
| 10 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.92701593 |
| 11 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.92117155 |
| 12 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.86227264 |
| 13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.84587705 |
| 14 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.77937060 |
| 15 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.63164313 |
| 16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.56824660 |
| 17 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.50828821 |
| 18 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.49875933 |
| 19 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.46928890 |
| 20 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.46745906 |
| 21 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.41704491 |
| 22 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.32609630 |
| 23 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.31464243 |
| 24 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.29278105 |
| 25 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.24879047 |
| 26 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.22689557 |
| 27 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.21995349 |
| 28 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.19901582 |
| 29 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 2.18360874 |
| 30 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.04828061 |
| 31 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.97049973 |
| 32 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.88076686 |
| 33 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.87131579 |
| 34 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.85515169 |
| 35 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.83400500 |
| 36 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.74920541 |
| 37 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.71557620 |
| 38 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.66095417 |
| 39 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.63757982 |
| 40 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.63746044 |
| 41 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.62232544 |
| 42 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.61896455 |
| 43 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.61867849 |
| 44 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.61057827 |
| 45 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.59555410 |
| 46 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.54423789 |
| 47 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54389501 |
| 48 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.49623747 |
| 49 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.48926434 |
| 50 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.37953076 |
| 51 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.37363354 |
| 52 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.37084401 |
| 53 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.35186370 |
| 54 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.29468284 |
| 55 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.28878362 |
| 56 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.28788414 |
| 57 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.27181216 |
| 58 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.25654768 |
| 59 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.25367009 |
| 60 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.24058084 |
| 61 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.22674592 |
| 62 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.22546491 |
| 63 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.21725624 |
| 64 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.21441266 |
| 65 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.20810366 |
| 66 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.19330142 |
| 67 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.17416615 |
| 68 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.17299268 |
| 69 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.17228961 |
| 70 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.16163987 |
| 71 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.15028983 |
| 72 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.14291870 |
| 73 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14246333 |
| 74 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.12767020 |
| 75 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.12197721 |
| 76 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.11139947 |
| 77 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.10788734 |
| 78 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.09925583 |
| 79 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.09779991 |
| 80 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.09244845 |
| 81 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.07425111 |
| 82 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05736949 |
| 83 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.05153661 |
| 84 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.02242141 |
| 85 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.01888673 |
| 86 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.01587038 |
| 87 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.00962797 |
| 88 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.00289360 |
| 89 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.93817496 |
| 90 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.93257268 |
| 91 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.92862208 |
| 92 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.91790357 |
| 93 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.91384528 |
| 94 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.90544103 |
| 95 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.89988859 |
| 96 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.86358851 |
| 97 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.86078773 |
| 98 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.85519763 |
| 99 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.84248695 |
| 100 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.83975022 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010094_abnormal_chromosome_stability | 3.46750053 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 3.37231753 |
| 3 | MP0003693_abnormal_embryo_hatching | 3.28509605 |
| 4 | MP0004957_abnormal_blastocyst_morpholog | 3.27649071 |
| 5 | MP0003111_abnormal_nucleus_morphology | 3.07995703 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 2.81626535 |
| 7 | MP0009697_abnormal_copulation | 2.79184980 |
| 8 | MP0003077_abnormal_cell_cycle | 2.71296527 |
| 9 | MP0005451_abnormal_body_composition | 2.67476723 |
| 10 | MP0008932_abnormal_embryonic_tissue | 2.62147630 |
| 11 | MP0004233_abnormal_muscle_weight | 2.59985224 |
| 12 | MP0000751_myopathy | 2.53000812 |
| 13 | MP0008058_abnormal_DNA_repair | 2.52320841 |
| 14 | MP0000749_muscle_degeneration | 2.37315850 |
| 15 | MP0006036_abnormal_mitochondrial_physio | 2.23812083 |
| 16 | MP0005330_cardiomyopathy | 2.05235790 |
| 17 | MP0008057_abnormal_DNA_replication | 2.03067160 |
| 18 | MP0003186_abnormal_redox_activity | 1.99035996 |
| 19 | MP0008007_abnormal_cellular_replicative | 1.92609741 |
| 20 | MP0001661_extended_life_span | 1.89725182 |
| 21 | MP0004145_abnormal_muscle_electrophysio | 1.84245979 |
| 22 | MP0002269_muscular_atrophy | 1.82395091 |
| 23 | MP0002877_abnormal_melanocyte_morpholog | 1.82079496 |
| 24 | MP0001730_embryonic_growth_arrest | 1.78072232 |
| 25 | MP0000747_muscle_weakness | 1.73650051 |
| 26 | MP0005360_urolithiasis | 1.72907076 |
| 27 | MP0003705_abnormal_hypodermis_morpholog | 1.71388981 |
| 28 | MP0004036_abnormal_muscle_relaxation | 1.70596024 |
| 29 | MP0003646_muscle_fatigue | 1.60792332 |
| 30 | MP0004087_abnormal_muscle_fiber | 1.55726340 |
| 31 | MP0003718_maternal_effect | 1.55347819 |
| 32 | MP0010234_abnormal_vibrissa_follicle | 1.51692548 |
| 33 | MP0003221_abnormal_cardiomyocyte_apopto | 1.50577447 |
| 34 | MP0006035_abnormal_mitochondrial_morpho | 1.47069200 |
| 35 | MP0005085_abnormal_gallbladder_physiolo | 1.46752827 |
| 36 | MP0004084_abnormal_cardiac_muscle | 1.45220492 |
| 37 | MP0005408_hypopigmentation | 1.45075523 |
| 38 | MP0000759_abnormal_skeletal_muscle | 1.41605675 |
| 39 | MP0003786_premature_aging | 1.41362454 |
| 40 | MP0010030_abnormal_orbit_morphology | 1.40194932 |
| 41 | MP0002837_dystrophic_cardiac_calcinosis | 1.39626246 |
| 42 | MP0000350_abnormal_cell_proliferation | 1.37439798 |
| 43 | MP0005332_abnormal_amino_acid | 1.30341935 |
| 44 | MP0000372_irregular_coat_pigmentation | 1.28465733 |
| 45 | MP0004215_abnormal_myocardial_fiber | 1.28154413 |
| 46 | MP0001697_abnormal_embryo_size | 1.24790580 |
| 47 | MP0004147_increased_porphyrin_level | 1.22619795 |
| 48 | MP0002080_prenatal_lethality | 1.22557595 |
| 49 | MP0005365_abnormal_bile_salt | 1.18373590 |
| 50 | MP0009840_abnormal_foam_cell | 1.17293653 |
| 51 | MP0001672_abnormal_embryogenesis/_devel | 1.16757954 |
| 52 | MP0005380_embryogenesis_phenotype | 1.16757954 |
| 53 | MP0005257_abnormal_intraocular_pressure | 1.16553713 |
| 54 | MP0000750_abnormal_muscle_regeneration | 1.16165591 |
| 55 | MP0009672_abnormal_birth_weight | 1.15674675 |
| 56 | MP0002938_white_spotting | 1.13502219 |
| 57 | MP0000358_abnormal_cell_content/ | 1.12087106 |
| 58 | MP0003868_abnormal_feces_composition | 1.09361990 |
| 59 | MP0001529_abnormal_vocalization | 1.09048993 |
| 60 | MP0010352_gastrointestinal_tract_polyps | 1.07784332 |
| 61 | MP0003984_embryonic_growth_retardation | 1.06470039 |
| 62 | MP0003950_abnormal_plasma_membrane | 1.05577922 |
| 63 | MP0002106_abnormal_muscle_physiology | 1.05219170 |
| 64 | MP0010630_abnormal_cardiac_muscle | 1.04938383 |
| 65 | MP0009379_abnormal_foot_pigmentation | 1.03339892 |
| 66 | MP0002972_abnormal_cardiac_muscle | 1.03015748 |
| 67 | MP0002088_abnormal_embryonic_growth/wei | 1.01027529 |
| 68 | MP0004185_abnormal_adipocyte_glucose | 0.96828668 |
| 69 | MP0005266_abnormal_metabolism | 0.94960549 |
| 70 | MP0005501_abnormal_skin_physiology | 0.93204097 |
| 71 | MP0003315_abnormal_perineum_morphology | 0.92680466 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 0.92629686 |
| 73 | MP0000313_abnormal_cell_death | 0.92395591 |
| 74 | MP0001727_abnormal_embryo_implantation | 0.90110045 |
| 75 | MP0006138_congestive_heart_failure | 0.89236108 |
| 76 | MP0001764_abnormal_homeostasis | 0.88836210 |
| 77 | MP0008875_abnormal_xenobiotic_pharmacok | 0.88787509 |
| 78 | MP0002084_abnormal_developmental_patter | 0.83849135 |
| 79 | MP0003566_abnormal_cell_adhesion | 0.81694443 |
| 80 | MP0002085_abnormal_embryonic_tissue | 0.81082981 |
| 81 | MP0001544_abnormal_cardiovascular_syste | 0.80159811 |
| 82 | MP0005385_cardiovascular_system_phenoty | 0.80159811 |
| 83 | MP0005620_abnormal_muscle_contractility | 0.79177673 |
| 84 | MP0005369_muscle_phenotype | 0.78116708 |
| 85 | MP0008775_abnormal_heart_ventricle | 0.77145391 |
| 86 | MP0008789_abnormal_olfactory_epithelium | 0.75941898 |
| 87 | MP0001666_abnormal_nutrient_absorption | 0.75451683 |
| 88 | MP0002086_abnormal_extraembryonic_tissu | 0.73084701 |
| 89 | MP0000733_abnormal_muscle_development | 0.72854479 |
| 90 | MP0000003_abnormal_adipose_tissue | 0.72568896 |
| 91 | MP0002638_abnormal_pupillary_reflex | 0.72358342 |
| 92 | MP0002210_abnormal_sex_determination | 0.71911582 |
| 93 | MP0004272_abnormal_basement_membrane | 0.71093793 |
| 94 | MP0000609_abnormal_liver_physiology | 0.70074494 |
| 95 | MP0008438_abnormal_cutaneous_collagen | 0.69761761 |
| 96 | MP0000678_abnormal_parathyroid_gland | 0.66981188 |
| 97 | MP0005319_abnormal_enzyme/_coenzyme | 0.66352347 |
| 98 | MP0005666_abnormal_adipose_tissue | 0.65776082 |
| 99 | MP0010307_abnormal_tumor_latency | 0.65523964 |
| 100 | MP0003123_paternal_imprinting | 0.65052453 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolysis (HP:0004366) | 4.72767813 |
| 2 | Increased serum pyruvate (HP:0003542) | 4.59308949 |
| 3 | Nemaline bodies (HP:0003798) | 4.11841871 |
| 4 | Muscle fiber inclusion bodies (HP:0100299) | 4.01635084 |
| 5 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.98974655 |
| 6 | Exercise-induced muscle cramps (HP:0003710) | 3.55352530 |
| 7 | Rhabdomyolysis (HP:0003201) | 3.55255845 |
| 8 | Myoglobinuria (HP:0002913) | 3.39741940 |
| 9 | Abnormal gallbladder physiology (HP:0012438) | 3.36279204 |
| 10 | Cholecystitis (HP:0001082) | 3.36279204 |
| 11 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.25510165 |
| 12 | Acute encephalopathy (HP:0006846) | 3.22175836 |
| 13 | Cerebral edema (HP:0002181) | 3.17102583 |
| 14 | Acute necrotizing encephalopathy (HP:0006965) | 3.05875999 |
| 15 | Ragged-red muscle fibers (HP:0003200) | 3.02516432 |
| 16 | Exercise-induced myalgia (HP:0003738) | 3.00243896 |
| 17 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.90656469 |
| 18 | Abnormality of methionine metabolism (HP:0010901) | 2.74556517 |
| 19 | Increased intramyocellular lipid droplets (HP:0012240) | 2.74312671 |
| 20 | Progressive muscle weakness (HP:0003323) | 2.67760376 |
| 21 | Hepatic necrosis (HP:0002605) | 2.67461704 |
| 22 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.65790476 |
| 23 | Hyperammonemia (HP:0001987) | 2.63345619 |
| 24 | Hypobetalipoproteinemia (HP:0003563) | 2.61198322 |
| 25 | Reticulocytopenia (HP:0001896) | 2.55203797 |
| 26 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.54687513 |
| 27 | Microvesicular hepatic steatosis (HP:0001414) | 2.52638647 |
| 28 | Exercise intolerance (HP:0003546) | 2.52457037 |
| 29 | Type 1 muscle fiber predominance (HP:0003803) | 2.50460474 |
| 30 | Increased CSF lactate (HP:0002490) | 2.50319497 |
| 31 | Increased muscle lipid content (HP:0009058) | 2.46884648 |
| 32 | Cholelithiasis (HP:0001081) | 2.46363915 |
| 33 | Increased connective tissue (HP:0009025) | 2.43327012 |
| 34 | Macrocytic anemia (HP:0001972) | 2.43008671 |
| 35 | Rimmed vacuoles (HP:0003805) | 2.42545616 |
| 36 | Hepatocellular necrosis (HP:0001404) | 2.40896345 |
| 37 | Mitochondrial inheritance (HP:0001427) | 2.39996337 |
| 38 | Cortical dysplasia (HP:0002539) | 2.38269646 |
| 39 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.37739842 |
| 40 | EMG: myopathic abnormalities (HP:0003458) | 2.37590199 |
| 41 | Increased hepatocellular lipid droplets (HP:0006565) | 2.37242871 |
| 42 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.36903812 |
| 43 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.36903812 |
| 44 | Lipid accumulation in hepatocytes (HP:0006561) | 2.32762755 |
| 45 | Chromsome breakage (HP:0040012) | 2.31837708 |
| 46 | Reduced antithrombin III activity (HP:0001976) | 2.27063230 |
| 47 | Gout (HP:0001997) | 2.26686558 |
| 48 | Myopathic facies (HP:0002058) | 2.26134029 |
| 49 | Achilles tendon contracture (HP:0001771) | 2.25693137 |
| 50 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.24602107 |
| 51 | * Lactic acidosis (HP:0003128) | 2.23945666 |
| 52 | Increased serum lactate (HP:0002151) | 2.23469048 |
| 53 | Progressive macrocephaly (HP:0004481) | 2.22680807 |
| 54 | Abnormality of reticulocytes (HP:0004312) | 2.21549945 |
| 55 | Abnormal gallbladder morphology (HP:0012437) | 2.19995418 |
| 56 | Calcaneovalgus deformity (HP:0001848) | 2.19681765 |
| 57 | Generalized aminoaciduria (HP:0002909) | 2.18965273 |
| 58 | Abnormality of the Achilles tendon (HP:0005109) | 2.18929383 |
| 59 | Multiple enchondromatosis (HP:0005701) | 2.12777807 |
| 60 | Abnormality of serum amino acid levels (HP:0003112) | 2.11546033 |
| 61 | Shoulder girdle muscle weakness (HP:0003547) | 2.11502129 |
| 62 | Hypoglycemic coma (HP:0001325) | 2.11176106 |
| 63 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.07718491 |
| 64 | Abnormality of alanine metabolism (HP:0010916) | 2.07718491 |
| 65 | Hyperalaninemia (HP:0003348) | 2.07718491 |
| 66 | Muscle stiffness (HP:0003552) | 2.06097146 |
| 67 | Reticulocytosis (HP:0001923) | 2.05608647 |
| 68 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.04836058 |
| 69 | Distal lower limb muscle weakness (HP:0009053) | 2.04279048 |
| 70 | Neck muscle weakness (HP:0000467) | 2.03077810 |
| 71 | Abnormality of the tricuspid valve (HP:0001702) | 2.02224200 |
| 72 | Sudden death (HP:0001699) | 2.02217651 |
| 73 | Hypokinesia (HP:0002375) | 2.01184511 |
| 74 | Progressive external ophthalmoplegia (HP:0000590) | 1.95446803 |
| 75 | Dilated cardiomyopathy (HP:0001644) | 1.94663008 |
| 76 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.93360429 |
| 77 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.92962154 |
| 78 | Hypolipoproteinemia (HP:0010981) | 1.90377527 |
| 79 | Prolonged partial thromboplastin time (HP:0003645) | 1.88041642 |
| 80 | Respiratory failure (HP:0002878) | 1.85562414 |
| 81 | Birth length less than 3rd percentile (HP:0003561) | 1.85135521 |
| 82 | Deformed tarsal bones (HP:0008119) | 1.83890857 |
| 83 | Intrahepatic cholestasis (HP:0001406) | 1.83262006 |
| 84 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.83259537 |
| 85 | Overlapping toe (HP:0001845) | 1.82707638 |
| 86 | Abnormality of the calf musculature (HP:0001430) | 1.82579307 |
| 87 | Abnormality of the gallbladder (HP:0005264) | 1.81596640 |
| 88 | Hyperbilirubinemia (HP:0002904) | 1.81386236 |
| 89 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.81089969 |
| 90 | Type I transferrin isoform profile (HP:0003642) | 1.80053524 |
| 91 | Lipoatrophy (HP:0100578) | 1.79538862 |
| 92 | Abnormality of the anterior horn cell (HP:0006802) | 1.78914536 |
| 93 | Degeneration of anterior horn cells (HP:0002398) | 1.78914536 |
| 94 | Palpitations (HP:0001962) | 1.78797682 |
| 95 | Nausea (HP:0002018) | 1.75928400 |
| 96 | Bundle branch block (HP:0011710) | 1.75625813 |
| 97 | Ventricular tachycardia (HP:0004756) | 1.75233915 |
| 98 | Limb-girdle muscle atrophy (HP:0003797) | 1.74893489 |
| 99 | Abnormality of the calcaneus (HP:0008364) | 1.74720540 |
| 100 | Deep venous thrombosis (HP:0002625) | 1.74607633 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NEK1 | 4.28614430 |
| 2 | BUB1 | 3.91551287 |
| 3 | TTK | 3.04347900 |
| 4 | PBK | 2.99079269 |
| 5 | NME2 | 2.94517762 |
| 6 | EIF2AK1 | 2.87112511 |
| 7 | CDC7 | 2.82433094 |
| 8 | PDK2 | 2.79710248 |
| 9 | OBSCN | 2.43356297 |
| 10 | SRPK1 | 2.39163336 |
| 11 | SCYL2 | 2.29490756 |
| 12 | WEE1 | 2.17768532 |
| 13 | TTN | 2.16016075 |
| 14 | TSSK6 | 1.98870014 |
| 15 | VRK2 | 1.95301787 |
| 16 | MST1R | 1.92723537 |
| 17 | EIF2AK3 | 1.89163669 |
| 18 | CCNB1 | 1.84390881 |
| 19 | STK16 | 1.71832917 |
| 20 | NME1 | 1.60730629 |
| 21 | MAP3K12 | 1.57775523 |
| 22 | PAK4 | 1.48912101 |
| 23 | PLK4 | 1.42094241 |
| 24 | IRAK3 | 1.38250543 |
| 25 | LATS2 | 1.35432778 |
| 26 | BRSK2 | 1.33660115 |
| 27 | PLK1 | 1.32977713 |
| 28 | ARAF | 1.31411818 |
| 29 | BRSK1 | 1.28876320 |
| 30 | MET | 1.21605079 |
| 31 | RPS6KB2 | 1.20396819 |
| 32 | AURKB | 1.17661091 |
| 33 | BRAF | 1.17109161 |
| 34 | PHKG1 | 1.16202668 |
| 35 | PHKG2 | 1.16202668 |
| 36 | ICK | 1.14795865 |
| 37 | LIMK1 | 1.12573098 |
| 38 | CHEK2 | 1.09944750 |
| 39 | SMG1 | 1.08304324 |
| 40 | PLK3 | 1.07813219 |
| 41 | EEF2K | 1.05541131 |
| 42 | AURKA | 1.04202151 |
| 43 | MAP3K8 | 1.04143645 |
| 44 | NEK9 | 0.99878044 |
| 45 | NEK2 | 0.98022265 |
| 46 | KSR2 | 0.95762087 |
| 47 | CDK7 | 0.90990166 |
| 48 | VRK1 | 0.89067803 |
| 49 | MYLK | 0.88380191 |
| 50 | ATR | 0.87031883 |
| 51 | TESK1 | 0.86962877 |
| 52 | ZAK | 0.81722492 |
| 53 | ERBB4 | 0.81469496 |
| 54 | EPHA2 | 0.81263647 |
| 55 | CDK8 | 0.80268592 |
| 56 | CHEK1 | 0.79644362 |
| 57 | RAF1 | 0.79190344 |
| 58 | PIM2 | 0.74326206 |
| 59 | AKT2 | 0.73479617 |
| 60 | TAF1 | 0.71345339 |
| 61 | ILK | 0.65365170 |
| 62 | BCKDK | 0.63756297 |
| 63 | MKNK1 | 0.62086083 |
| 64 | CLK1 | 0.62080761 |
| 65 | CSNK2A2 | 0.59091851 |
| 66 | STK4 | 0.57025773 |
| 67 | ABL2 | 0.54841854 |
| 68 | CDK11A | 0.54427825 |
| 69 | EIF2AK2 | 0.53695644 |
| 70 | TAOK2 | 0.52303577 |
| 71 | PTK2 | 0.51930891 |
| 72 | CDK14 | 0.51243006 |
| 73 | KSR1 | 0.51231216 |
| 74 | DAPK3 | 0.50978775 |
| 75 | CDK4 | 0.50792113 |
| 76 | CDK15 | 0.50512845 |
| 77 | PAK1 | 0.50439415 |
| 78 | CSNK2A1 | 0.49870612 |
| 79 | MAPKAPK5 | 0.49802401 |
| 80 | ALK | 0.49760977 |
| 81 | CDK18 | 0.49104703 |
| 82 | MOS | 0.49084876 |
| 83 | CDK1 | 0.48981340 |
| 84 | ATM | 0.47955509 |
| 85 | CSNK1E | 0.46635295 |
| 86 | ERBB3 | 0.44158631 |
| 87 | CDK2 | 0.42090283 |
| 88 | PAK2 | 0.40274391 |
| 89 | MST4 | 0.40180648 |
| 90 | CDK6 | 0.40018841 |
| 91 | TRIB3 | 0.38586170 |
| 92 | CAMK2G | 0.38106646 |
| 93 | DMPK | 0.37801595 |
| 94 | PASK | 0.36182827 |
| 95 | TESK2 | 0.36052831 |
| 96 | CSNK1G3 | 0.33380028 |
| 97 | STK24 | 0.29990323 |
| 98 | MAP3K10 | 0.29086579 |
| 99 | DAPK1 | 0.28868797 |
| 100 | LMTK2 | 0.28568622 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.50866689 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.27397958 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.99423856 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 2.94790169 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 2.64359909 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 2.52848464 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.45059238 |
| 8 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.42240701 |
| 9 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.40189419 |
| 10 | Ribosome_Homo sapiens_hsa03010 | 2.37674236 |
| 11 | * Carbon metabolism_Homo sapiens_hsa01200 | 2.32449281 |
| 12 | * Pyruvate metabolism_Homo sapiens_hsa00620 | 2.18800454 |
| 13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.90731183 |
| 14 | Parkinsons disease_Homo sapiens_hsa05012 | 1.90254741 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.88111281 |
| 16 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.78904899 |
| 17 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.75818299 |
| 18 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.69072964 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.68986846 |
| 20 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.67313150 |
| 21 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.61463349 |
| 22 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.59878503 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.50344541 |
| 24 | Base excision repair_Homo sapiens_hsa03410 | 1.49491271 |
| 25 | Cell cycle_Homo sapiens_hsa04110 | 1.47641984 |
| 26 | RNA transport_Homo sapiens_hsa03013 | 1.43841758 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.41602403 |
| 28 | Sulfur relay system_Homo sapiens_hsa04122 | 1.39554259 |
| 29 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.38065256 |
| 30 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.37568662 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.36717425 |
| 32 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.36664112 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.36642234 |
| 34 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.35515074 |
| 35 | Spliceosome_Homo sapiens_hsa03040 | 1.32813173 |
| 36 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.25996402 |
| 37 | Huntingtons disease_Homo sapiens_hsa05016 | 1.23440017 |
| 38 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.21158934 |
| 39 | Alzheimers disease_Homo sapiens_hsa05010 | 1.20881238 |
| 40 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.20606600 |
| 41 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.20511976 |
| 42 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.20327162 |
| 43 | Homologous recombination_Homo sapiens_hsa03440 | 1.20166531 |
| 44 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.17803460 |
| 45 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.15891917 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.12647468 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.08867178 |
| 48 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.07537945 |
| 49 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.07413019 |
| 50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.05763993 |
| 51 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.05194191 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.04588168 |
| 53 | Protein export_Homo sapiens_hsa03060 | 1.04179820 |
| 54 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.00995172 |
| 55 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.00986487 |
| 56 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.99614071 |
| 57 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.98133102 |
| 58 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.96407820 |
| 59 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.94303945 |
| 60 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.94018073 |
| 61 | RNA polymerase_Homo sapiens_hsa03020 | 0.93246371 |
| 62 | Galactose metabolism_Homo sapiens_hsa00052 | 0.89825409 |
| 63 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.86798155 |
| 64 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.84297751 |
| 65 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.84007297 |
| 66 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.73585334 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.71290858 |
| 68 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.70014976 |
| 69 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.69011615 |
| 70 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.66890527 |
| 71 | Peroxisome_Homo sapiens_hsa04146 | 0.65273855 |
| 72 | Purine metabolism_Homo sapiens_hsa00230 | 0.65136732 |
| 73 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.64424624 |
| 74 | Retinol metabolism_Homo sapiens_hsa00830 | 0.63299269 |
| 75 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.62322079 |
| 76 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.61231523 |
| 77 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.60895122 |
| 78 | RNA degradation_Homo sapiens_hsa03018 | 0.59575706 |
| 79 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.58332462 |
| 80 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.57098734 |
| 81 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.53102826 |
| 82 | Prion diseases_Homo sapiens_hsa05020 | 0.51851892 |
| 83 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.51401078 |
| 84 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.51208096 |
| 85 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.48353319 |
| 86 | Basal transcription factors_Homo sapiens_hsa03022 | 0.44712592 |
| 87 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.42241308 |
| 88 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.41114272 |
| 89 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.39518524 |
| 90 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.38846596 |
| 91 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.37516806 |
| 92 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.36702108 |
| 93 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.35343042 |
| 94 | Thyroid cancer_Homo sapiens_hsa05216 | 0.34999826 |
| 95 | Lysine degradation_Homo sapiens_hsa00310 | 0.32224001 |
| 96 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.30342376 |
| 97 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.28295123 |
| 98 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.27653008 |
| 99 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.24557204 |
| 100 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.23873531 |

